Hyperkinetic child treatment agent

Details Hyperkinetic child treatment agent Hyperkinetic child treatment agent

1983-09-12

1984-11-20

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

A61K 31485

Patent

active

044838603

ABSTRACT:
A method of orally treating a child having a tendency to be overactive to the extent of requiring an external control which comprises orally administering to said child a pharmaceutically effective amount of (-)-17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxymorpinan-6-one to said patient, whereby the attention span of the child lengthened. An oral sustained release dosage unit containing (-)-17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxymorpinan-6-one is disclosed also.

REFERENCES:
Chem. Abst. 10th Collective Index, Chem. Substance: Methanediamine-1-Naphthalenol.

Affiliated with

Also associated with

Rating

Hyperkinetic child treatment agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hyperkinetic child treatment agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hyperkinetic child treatment agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2189062